Autoimmune pulmonary alveolar proteinosis in a patient with sarcoidosis

Steroids used to treat sarcoidosis may induce aPAP. The cooccurrence of sarcoidosis and autoimmune pulmonary alveolar proteinosis (aPAP) is rare. In this case, aPAP merged into sarcoidosis regardless of the disease state of sarcoidosis and improved naturally. When using steroids during sarcoidosis e...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Yuko, Shirai, Toshihiro, Asada, Kazuhiro, Muramatsu, Aya, Katsumata, Mineo, Suda, Takafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452467/
https://www.ncbi.nlm.nih.gov/pubmed/30997074
http://dx.doi.org/10.1002/ccr3.2068
_version_ 1783409294698348544
author Tanaka, Yuko
Shirai, Toshihiro
Asada, Kazuhiro
Muramatsu, Aya
Katsumata, Mineo
Suda, Takafumi
author_facet Tanaka, Yuko
Shirai, Toshihiro
Asada, Kazuhiro
Muramatsu, Aya
Katsumata, Mineo
Suda, Takafumi
author_sort Tanaka, Yuko
collection PubMed
description Steroids used to treat sarcoidosis may induce aPAP. The cooccurrence of sarcoidosis and autoimmune pulmonary alveolar proteinosis (aPAP) is rare. In this case, aPAP merged into sarcoidosis regardless of the disease state of sarcoidosis and improved naturally. When using steroids during sarcoidosis exacerbation, attention should be paid to aPAP relapse.
format Online
Article
Text
id pubmed-6452467
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64524672019-04-17 Autoimmune pulmonary alveolar proteinosis in a patient with sarcoidosis Tanaka, Yuko Shirai, Toshihiro Asada, Kazuhiro Muramatsu, Aya Katsumata, Mineo Suda, Takafumi Clin Case Rep Case Reports Steroids used to treat sarcoidosis may induce aPAP. The cooccurrence of sarcoidosis and autoimmune pulmonary alveolar proteinosis (aPAP) is rare. In this case, aPAP merged into sarcoidosis regardless of the disease state of sarcoidosis and improved naturally. When using steroids during sarcoidosis exacerbation, attention should be paid to aPAP relapse. John Wiley and Sons Inc. 2019-03-02 /pmc/articles/PMC6452467/ /pubmed/30997074 http://dx.doi.org/10.1002/ccr3.2068 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Tanaka, Yuko
Shirai, Toshihiro
Asada, Kazuhiro
Muramatsu, Aya
Katsumata, Mineo
Suda, Takafumi
Autoimmune pulmonary alveolar proteinosis in a patient with sarcoidosis
title Autoimmune pulmonary alveolar proteinosis in a patient with sarcoidosis
title_full Autoimmune pulmonary alveolar proteinosis in a patient with sarcoidosis
title_fullStr Autoimmune pulmonary alveolar proteinosis in a patient with sarcoidosis
title_full_unstemmed Autoimmune pulmonary alveolar proteinosis in a patient with sarcoidosis
title_short Autoimmune pulmonary alveolar proteinosis in a patient with sarcoidosis
title_sort autoimmune pulmonary alveolar proteinosis in a patient with sarcoidosis
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452467/
https://www.ncbi.nlm.nih.gov/pubmed/30997074
http://dx.doi.org/10.1002/ccr3.2068
work_keys_str_mv AT tanakayuko autoimmunepulmonaryalveolarproteinosisinapatientwithsarcoidosis
AT shiraitoshihiro autoimmunepulmonaryalveolarproteinosisinapatientwithsarcoidosis
AT asadakazuhiro autoimmunepulmonaryalveolarproteinosisinapatientwithsarcoidosis
AT muramatsuaya autoimmunepulmonaryalveolarproteinosisinapatientwithsarcoidosis
AT katsumatamineo autoimmunepulmonaryalveolarproteinosisinapatientwithsarcoidosis
AT sudatakafumi autoimmunepulmonaryalveolarproteinosisinapatientwithsarcoidosis

Ejemplares similares